Andrew J Kwilasz Selected Research

Adenosine A2 Receptor Agonists

1/2018

Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A2A receptor agonists.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew J Kwilasz Research Topics

Disease

5	Neuralgia (Stump Neuralgia) 10/2022 - 01/2018
5	Pain (Aches) 01/2021 - 11/2012
3	Hyperalgesia 01/2021 - 01/2018
2	Neuroinflammatory Diseases 01/2021 - 01/2019
2	Acute Pain 04/2014 - 11/2012
1	Infections 01/2022
1	Brain Diseases (Brain Disorder) 01/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Memory Disorders (Memory Loss) 01/2021
1	Chronic Pain 11/2019
1	Hypersensitivity (Allergy) 11/2019
1	Peripheral Nerve Injuries 11/2019
1	Tobacco Use Disorder (Nicotine Dependence) 11/2009

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 01/2022 - 01/2019
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2021 - 11/2019
2	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 01/2018
2	ATL 313IBA 01/2019 - 01/2018
2	Analgesics (Analgesic Drugs)IBA 04/2014 - 11/2012
1	NF-E2-Related Factor 2IBA 10/2022
1	Free RadicalsIBA 10/2022
1	Superoxides (Superoxide)IBA 10/2022
1	AntioxidantsIBA 10/2022
1	ChemokinesIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Toll-Like Receptor 4IBA 01/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021
1	Naltrexone (ReVia)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	Toll-Like Receptor 2IBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 11/2019
1	Oxycodone (Oxycontin)FDA LinkGeneric 11/2019
1	Fentanyl (Sublimaze)FDA LinkGeneric 11/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2019
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2019
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2018
1	Adenosine A2 Receptor AgonistsIBA 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2014
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 04/2014
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 04/2014
1	AcidsIBA 04/2014
1	Dronabinol (THC)FDA LinkGeneric 11/2012
1	CannabinoidsIBA 11/2012
1	Cannabinoid Receptor AgonistsIBA 11/2012
1	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 11/2012
1	Nicotine FDA Link 11/2009
1	Pharmaceutical PreparationsIBA 11/2009

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2019
1	Spinal Injections 01/2018